BioSpace News Archive

Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the opening for patient screening and enrollment of the IMpactMF Phase 3 clinical trial of imetelstat, a first-in-class telomerase inhibitor, in refractory myelofibrosis (MF).

Cerner Corporation (Nasdaq: CERN), a global health care technology company, today announced that its Board of Directors declared a cash dividend to stockholders of $0.22 per issued and outstanding share, up 22% from the prior quarterly dividend of $0.18. The cash dividend will be payable on Jan. 12, 2021, to shareholders of record as of the close of business on Dec. 28, 2020. Cerner intends to pay regular quarterly cash dividends, with fu

Exact Sciences Corp. (NASDAQ: EXAS) today announced the presentation of new data at the virtual 2020 San Antonio Breast Cancer Symposium (SABCS) building on the clinical value of the Oncotype DX Breast Recurrence Score® test.

The National Eating Disorders Association (NEDA) provides a critical grant through NEDA’s Feeding Hope Fund to support the Barriers to Treatment Access Study, led by Project HEAL in partnership with the Eating Anxiety Treatment (EAT) Lab at the University of Louisville . Eating disorders have some of the most complex and pervasive barr

CONTESSA Achieved Primary Endpoint – Tesetaxel Plus a Reduced Dose of Capecitabine Significantly Improved Progression-free Survival (PFS) Versus the Approved Dose of Capecitabine Alone (Hazard Ratio=0.716; p=0.003) Median PFS Was 9.8 Months for Tesetaxel Plus a Reduced Dose of Capecitabine Versus 6.9 Months for the Approved Dose of Capecitabine Alone, an Improvement of 2.9 Months

Global life sciences and diagnostics company advances environmental goals; invests more than $5M in sustainability-focused initiatives

- Increase reflects strength and sustainability of Abbott’s diversified business - Dividend increased for 49th consecutive year - Abbott remains an S&P 500 Dividend Aristocrat

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, today announced that it has entered into agreements with several institutional and accredited investors (the “Exercising Holders”) to exercise certain outstanding warrants to purchase an aggregate of up to 3,964,065 shares of common stock raising gross proce

Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the National Comprehensive Cancer Network® (NCCN) added three different XPOVIO® (selinexor) combination regimens to its Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for previou

MyMedBot, a digital health start-up helping organizations reopen safely during the Coronavirus pandemic, has announced that it will integrate a COVID-19 vaccination management system into its health screening solution